Thomas Schnibbe

Thomas Schnibbe is CEO of CELLnTEC Advanced Cell Systems, Switzerland, a pioneering developer and manufacturer of fully defined precision media for primary and stem cell research, and supplier to the regenerative medicine industry. Dr. Schnibbe obtained his PhD at the Max Planck Institute for Molecular Genetics, Berlin, and an MSc in Biotechnology from the Technical University of Braunschweig, Germany, with study and research stays at the Technical University of Munich and the Helmholtz Centre for Infection Research, Braunschweig, Germany, and Kyoto University, Japan. With more than 20 years of experience in the biotechnology industry, Dr. Schnibbe previously held senior positions in both business and technology development at QIAGEN, Chiron Corporation (now part of Novartis), and in technology consulting in Europe and the United States.